Strides Pharma recalls over 6 lakh bottles of blood pressure treatment tablets in United States

The tablets that have been affected by this move, in strengths of 25 mg, 50mg, and 100 mg, were manufactured by Vivimed Life Sciences in a Tamil Nadu-based plant and distributed in the US market by New Jersey-based Strides Pharma Inc.

Strides Pharma, blood pressure, USFDA, health news, Pharma news,
As per the USFDA, the company has initiated Class II recall due to "CGMP (current good manufacturing practices) deviations". (File)

Strides Pharma Inc is recalling over six lakh bottles of blood pressure-lowering drug Losartan Potassium tablets in the US market in multiple strengths due to deviation from standard manufacturing norms, according to a USFDA report.

As per the latest enforcement report by the US Food and Drug Administration (USFDA), the company, which is a unit of Bengaluru-headquartered Strides Pharma Science, is recalling 6,78,829 bottles of the blood pressure-lowering drug in the US market, as reported by news agency PTI.

The affected lot of tables, in strengths of 25 mg, 50mg, and 100 mg, have been manufactured by Vivimed Life Sciences in a Tamil Nadu-based plant and distributed in the US market by New Jersey-based Strides Pharma Inc. As per the USFDA, the company has initiated Class II recall due to “CGMP (current good manufacturing practices) deviations”.

The US health regulator noted that the AZIDO impurity levels were observed to be above acceptable limits. As per the USFDA report, Strides Pharma Inc is recalling 2,00,407 bottles of 25 mg Losartan Potassium tablets, 3,81,456 bottles of 50 mg tablets, and 96,966 bottles of 100 mg tablets, as part of the nationwide (US) recall, which the company initiated on May 18 this year.

As per the USFDA, a class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

The US generic drug market was estimated to be around USD 115.2 billion in 2019. It is the largest market for pharmaceutical products. Strides Pharma Science’s global manufacturing sites are located in India (Chennai, Puducherry and two locations in Bengaluru), Singapore, Italy (Milan), Kenya (Nairobi) and the US (New York).
The company focuses on “difficult to manufacture” products that are sold in over 100 countries.

(With inputs from PTI)

Get live Share Market updates and latest India News and business news on Financial Express. Download Financial Express App for latest business news.

Most Read In News Healthcare
Photos